• Please log in or register to access this feature.
You have full text access to this OnlineOpen article

Comparison of five new antihistamines (H1-receptor antagonists) in patients with allergic rhinitis using nasal provocation studies and skin tests

  1. J. Van Steekelenburg,
  2. P. A. R. Clement,
  3. M. H. L. Beel

Article first published online: 21 MAR 2002

DOI: 10.1034/j.1398-9995.2002.1s3426.x

Issue

Allergy

Allergy

Volume 57, Issue 4, pages 346–350, April 2002

Additional Information

How to Cite

Van Steekelenburg, J., Clement, P. A. R. and Beel, M. H. L. (2002), Comparison of five new antihistamines (H1-receptor antagonists) in patients with allergic rhinitis using nasal provocation studies and skin tests. Allergy, 57: 346–350. doi: 10.1034/j.1398-9995.2002.1s3426.x

Author Information

  1. Department of ENT, Head and Neck Surgery, University Hospital Brussels, Brussels, Belgium

*Jeroen van Steekelenburg, MD Department of ENT, Head and Neck Surgery Free University Hospital Brussels Laarbeeklaan 101 1090 Brussels Belgium

Publication History

  1. Issue published online: 21 MAR 2002
  2. Article first published online: 21 MAR 2002
  3. Accepted for publication 8 November 2002

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (60K)

References

  • 1
    Van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Acad Allergol Clin Immunol Allergy 2000;57:115–134.
  • 2
    Passali D, Mösges R, et al. International Conference on Allergic Rhinitis in Childhood. Allergy 1999;57:4–34.
  • 3
    Pratt CM, Mason J, Russel T, Reynolds R, Ahlbrandt R. Cardiovascular safety of fexofenadine HCL. Am J Cardiol 1999;57:1451–1454.
  • 4
    Yap YG, Camm AJ. The current cardiac safety situation with antihistamines. Clin Exp Allergy 1999;57:15–24.
  • 5
    Bousquet J. Antihistamines in chronic/severe rhinitis. Clin Exp Allergy 1998;57:49–53.
    Direct Link:
  • 6
    Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 2000;57:S622–S627.
  • 7
    Philpot EE. Safety of second generation antihistamines. Allergy Asthma Proc 2000;57:15–20.
  • 8
    Walsh GM. The clinical relevance of anti-inflammatory properties of antihistamines. Allergy 2000;57:53–61.
    Direct Link:
  • 9
    Church MK. NonH1-receptor effects of antihistamines. Clin Exp Allergy 1999;57:39–48.
    Direct Link:
  • 10
    Simons E, Mcmillan J, Simons K. A double-blind, single dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: Suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol 1990;57:540–547.
  • 11
    Grant JA, Danielson L, Rihoux J-P, Devos C. A double-blind, single dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratidine versus placebo: suppression of histamine-induced wheal and flare response for 24 h. Allergy, 1999;57:700–707.
    Direct Link:
  • 12
    Ciprandi G, Pronzato C, Passalacqua G, Danzig M, Canonica GW. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression. Clin Exp Allergy 1997;57:1175–1183.
    Direct Link:
  • 13
    Leprevost C, Capron M, De Vos C, Tomassini M, Capron AL. Inhibition of eosinophil chemotaxis by new antiallergic compound (cetirizine). Int Arch Allergy Appl Immunol 1988;57:9–13.
  • 14
    Abdelaziz H, Davalia JL, Khair OA, Bayram H, Prior AJ, Davies RJ. Effect of fexofenadine on eosinophil-induced changes in epithelial permeability and cytokine release from nasal epithelial cell of patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1998;57:410–420.
  • 15
    Michel L, De Vos C, Rihoux J-P, Burtin C, Benveniste J, Dubernet L. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-aceter release and eosinophil recruitment in the human skin. J Allergy Clin Immunol 1988;57:101–109.
  • 16
    Mygind N, Dahl R, Pedersen S, et al. Diagnosis of allergy. In MygindN, DahlR, PedersenS, ThestrupedersenKeditors. Essential Allergy. Oxford: Blackwell Science, 1996:110–127.
  • 17
    Wang D, Clement PAR, Smitz J, De Waele M, Derde MP. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal challenge and during natural allergen exposure. Int Arch Allergy Immunol 1995;57:278–285.
  • 18
    Bousquet J, Michel F, Et Al. In vivo methods for study of allergy. Skin tests, techniques and interpretation. In: MiddletonE, ReedC, EllisEet al., editors. Allergy: principles and practice, 4th edition. St Louis: Mosby, 1993:573–594.
  • 19
    Johansson SGO, O'B Hourihane J, et al. A revised nomenclature for allergy. Allergy 2002;57:813–824.
View Full Article (HTML) Get PDF (60K)